Patients with renal impairment and/or contrast allergies pose a challenge with regard to diagnostic evaluations. CO 2 may serve as a suitable alternative intravascular contrast agent in these patients with arteriographic applications, including evaluation of peripheral vascular disease, and venographic applications, such as transjugular intrahepatic portosystemic shunt procedure, to name a few. Unique properties of CO 2 , such as low viscosity, lack of an allergic reaction, and renal toxicity, have afforded it its diagnostic capabilities. However, certain properties of CO 2 also pose a technical challenge in terms of its delivery. Although it remains a relatively safe alternative contrast agent, potential adverse effects have been reported and exist.
The association of nephrogenic systemic fibrosis and of contrast-induced nephropathy (CIN) with iodinated contrast media (ICM) in patients with renal impairment has led to an increased interest in the search for alternative intravascular contrast agents, such as carbon dioxide (CO 2 ). CO 2 is a relatively safe alternative agent in those patients with chronic renal failure or an iodine contrast allergy undergoing angiographic examination. It has proven to be useful in a variety of angiographic applications, such as evaluation of arterial occlusive disease, venography, and arteriovenous fistulography. In addition, it has demonstrated an acceptable diagnostic accuracy comparable to ICM in a majority of cases. In the case of delineating portal vein anatomy in wedged hepatic venography during transjugular intrahepatic portosystemic shunt (TIPS) procedure, it has demonstrated superiority to ICM. However, the delivery of CO 2 can be challenging owing to its unique properties. Although relatively safe, potential adverse effects are well documented. In this article, we review the properties of CO 2 , its various arteriographic and venographic applications, delivery, and the potential complications and contraindications associated with its use.
Contrast-Induced Nephropathy
Using ICM, there is a risk of CIN in patients with impaired renal function. Although it is widely accepted that the risk of CIN is much greater with high osmolar contrast agents, the differences in the degree of nephrotoxicity between low osmolar contrast media and iso-osmolar contrast media has not been clearly established. 1, 2 Although the use of bicarbonate-based volume expansion has shown merit in reducing the risk of CIN, the use of N-acetylcysteine and other therapies has not shown consistent results. 2 Previously, gadolinium had been an alternative agent but increased awareness of nephrogenic systemic fibrosis risks in renal patients has limited its use.
3,4

CO 2 Properties
Although liquid contrast agents fill the lumen and mix with the blood to create radiographic contrast, CO 2 gas acts by displacing the blood within the vessel being studied, serving as a negative contrast agent because of its low atomic number when compared with iodinated contrast. Digital subtraction techniques then take advantage of the differences in radiographic density between the CO 2 and the lumen wall. 5, 6 Despite being heavier than air, the relative buoyancy of CO 2 may lead to incomplete filling, and thus displacement, of blood, leading to a lack of optimal contrast in large-caliber vessels. This may cause preferential filling of nondependent portions of vessels or preferential filling of various branches based on patient positioning (Fig 1) . 5, 7 As it is injected, dissolution of CO 2 into blood begins immediately without change in arterial blood gas parameters and systemic removal occurs by way of pulmonary expiration. 8 The low viscosity allowing delivery through small-caliber catheters, lack of nephrotoxicity, lack of an allergic reaction, and low cost are features making CO 2 a useful alternative contrast agent. 5, 7, 9 
Arteriographic Applications
The earliest application of CO 2 was in visualization of hepatic and portal veins and diagnosing pericardial disease. [10] [11] [12] [13] [14] Hawkins first reported the use of CO 2 as an arterial contrast agent in 1982. 15 Aside from the head, neck, and thorax, CO 2 may be used as a contrast agent in virtually any other angiographic diagnostic application. 8 
Atherosclerosis and Arterial Occlusive Disease
CO 2 has been shown to provide diagnostically useful images in the evaluation of peripheral arterial disease, owing its advantages to its low viscosity, affording it the ability to show small collateral branches, stenotic vessels, and the distal reconstituted vessel (Fig 2) . 5, 8 Several studies have reported the use of CO 2 as an alternative contrast agent with an acceptable diagnostic quality in lower limb peripheral arteries located above the knee (Figs 3 and 4) . [16] [17] [18] One experimental study showed that in densitometric evaluation of stenosis, CO 2 was occasionally superior to ICM in evaluation of a 50%-70% area of stenosis. 16 However, imaging of infrapopliteal vessels using CO 2 has not been reported to show such favorable results, 5, 18, [19] [20] [21] but selective catheterization in proximity to the vessel being evaluated may yield better results. Another potential limitation of CO 2 arteriography includes an overestimation of stenosis. Because of the dissolution of CO 2 in blood on injection, vessels with slow flow may not be adequately visualized and this lack of contrast may lead to an overestimation of the degree of stenosis. 8 In addition, an overestimation of vessel diameter by CO 2 when compared with intravenous ultrasound as a reference standard has been reported, thereby limiting accurate intervention planning, such as determination of proper stent size. The elastic nature of the vessel wall and expansile properties of CO 2 were attributed as the likely reasons for this behavior. 22 CO 2 angiography may also be used to evaluate abdominal aortic aneurysms. However, the high buoyancy and inadequate displacement of flowing blood in such a large-caliber vessel may lead to incomplete visualization of the entire lumen if a sufficient column of CO 2 is not used. In addition, the dependent renal arteries may not be well visualized in the supine position. Although the nondependent preference of CO 2 limits filling of the renal and lumbar vessels, CO 2 can provide information regarding involvement of anterior branches, such as the superior mesenteric artery (Fig 5) . [6] [7] [8] Thus, although the buoyancy of CO 2 allows evaluation of a proximal mesenteric stenosis, visualization of the distal mesenteric vessels is better with iodinated contrast agents.
8 CO 2 has also been successfully used as a contrast agent during endovascular repair of aortic aneurysms to confirm adequate deployment of the endostent. 23 A retrospective study comparing outcomes between 100 patients undergoing endovascular aortic aneurysm repair with ICM versus intravascular CO 2 showed no significant difference in outcome. However, increased fluoroscopy time associated with CO 2 was identified, most likely secondary to the technical challenges associated with CO 2 delivery. 24 
Renal Transplant and Renal Artery Evaluation
CO 2 angiography has also been used to evaluate patients with renal artery stenosis secondary to atherosclerosis or intimal hyperplasia in cases of renal transplantation (Fig 6) . Caridi et al were able to adequately visualize the renal vessels using simple maneuvering techniques, such as placing patients in the lateral decubitus position. [25] [26] [27] When compared with iodinated contrast, an 83% sensitivity and 99% specificity with an overall accuracy of 97% of CO 2 in evaluating renal stenosis has been reported. 28 A positive predictive value of greater than 90%, and in 1 study up to 100%, have been reported. 28, 29 Additionally, a prospective study of 123 patients revealed no correlation of nephrotoxicity and the amount of CO 2 injected. 30 Although these figures do not equal the diagnostic capabilities of ICM, CO 2 may have a role in appropriate settings. CO 2 has also been reported to demonstrate anastomotic stenosis, diffuse arterial disease related to chronic rejection, and arteriovenous fistulas after a renal transplant biopsy (Fig 7) . 31, 32 Thus, in patients with renal impairment, initial imaging may be performed with CO 2 followed by a smaller, reduced load of ICM to confirm the findings.
Venographic Applications
Venography
Similar to arteriography, wide applications of CO 2 as a contrast agent have been developed for patients with renal disease or an allergy to iodinated contrast media undergoing venography. One such application is CO 2 vena cavography to guide placement of inferior vena cava (IVC) filters. Dewald et al demonstrated a high success rate of CO 2 venography for IVC filter placement with visualization of venous anomalies in all cases and visualization of thrombus in an approximate 78% of cases. 33 The estimation of the IVC diameter carries a reported accuracy of approximately 97%. The reported accuracy of CO 2 venography in the identification of the renal veins varies depending on whether a dynamic series of images is used or a single static image. Filling defects in the IVC from the renal inflow of unopacified blood affords the dynamic images a higher success in the identification of the renal veins. 34, 35 However, the dependent location of the left renal vein may limit its visibility. Other applications include upper arm venography to guide placement of peripherally inserted central venous catheters and preoperative upper extremity venography for hemodialysis access fistulas. 36, 37 Perhaps the utility of CO 2 as an alternative contrast agent is no better demonstrated than in the visualization and identification of portal vein anatomy in wedged hepatic venography during a TIPS procedure (Fig 8) . CO 2 has been shown to be superior in identifying and delineating portal vein anatomy compared with iodinated contrast media due to its low viscosity, allowing it to easily traverse through the hepatic sinsusoids. [38] [39] [40] Sensitivity rates for opacification of the right and left portal veins have been reported as high as 94%. 41 In addition, the portal vein bifurcation can also be easily identified, helping guide the transhepatic puncture during TIPS. 8 Hawkins et al reports a technique whereby a 21-gauge needle is directly advanced into the liver parenchyma and CO 2 is injected to allow identification of the portal vein. 42 One must be careful not to abort a case in a false appearance of cavernous transformation caused by filling of hepatic lymphatic vessels. 43 Although it was initially reported that indirect arterial portography would still provide a better visualization of varices, recent experimental studies with CO 2 wedged arterial splenoportography have shown promise in visualization of gastric varices associated with splenic vein occlusion. 44, 45 In addition, the anastomotic site can also be evaluated with CO 2 portography in patients with a hepatic transplant (Fig 9) .
Arteriovenous Fistulography
The venous anastomosis of an arteriovenous fistula may be evaluated with CO 2 with a reported sensitivity, specificity, and diagnostic accuracy of 94%, 58%, and 75%, respectively (Fig 10) . When compared with 
FIG 7.
A 37-year-old male with renal allograft dysfunction. CO 2 arteriography in this renal transplant patient shows (A) the allograft renal artery anastomosed to the right internal iliac artery (arrow) and a (B) focal renal arterial stenosis (arrow). This was subsequently confirmed with iodinated contrast.
FIG 8. Wedged hepatic venography during TIPS procedure delineates the portal vein well (arrows).
iodinated contrast, CO 2 has a tendency to overestimate the degree of stenosis. 46 However, care must be taken not to reflux CO 2 into the arterial system during upper extremity fistulography to avoid potential neurologic damage, such as infarction.
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Delivery
Although there are unique properties of CO 2 that afford it certain advantages to be used as an alternative contrast agent, there are other unique properties that pose a technical challenge in delivering the agent. The colorless, odorless, and compressible nature of CO 2 requires the special attention needed in handling and injecting CO 2 . 8 Many methods for injection of CO 2 exist, including handheld syringes and plastic bag systems as well as dedicated injectors (Fig 11) . 47 Hand injection can be associated with potential complications, including delivery of an unknown volume. In addition, an "explosive delivery" of the gas has also been commonly described as a potential complication of hand injection occurring when the catheter used to inject CO 2 has fluid within it. With fluid in the catheter, a large force is required to expel the fluid from the catheter. The CO 2 is compressed against the fluid-catheter interface and once the fluid has exited the catheter, a sudden expansion of the CO 2 gas occurs, resulting in an "explosive delivery." 7, 8, 48 In an effort to allow controlled injection of CO 2 and prevent an "explosive delivery," a 3-mL syringe may be used to forcefully expel the fluid from the catheter using a 1-way valve before contrast administration. 8, 48 Because of Boyle's law (the inverse relationship of pressure and volume in an ideal gas), small volumes of gas delivered from pressurized CO 2 tank will expand to a large volume when exposed to atmospheric pressure or the patient's arterial pressure. Thus, the catheter should not be directly attached to the tank in an effort to prevent "explosive delivery." A syringe may be used to draw a volume of CO 2 and subsequently connect to the patient's intravascular catheter. However, a syringe connected directly to and under the pressure of the CO 2 tank will contain an indeterminate volume of CO 2 gas, which can potentially result in an excessive dose of CO 2 being delivered into the patient. Thus, previously it was thought that syringes could be transiently opened to room air and atmospheric pressure to prevent "explosive delivery." To prevent air contamination when the syringe is opened to room air, it was previously hypothesized that because CO 2 is heavier than air, the syringe should not be held upright (tip to the ground) as it may exit the catheter and be replaced by the lighter air. However, this was disproven and it was determined that inverting the syringe has no effect on air contamination. In fact, air contamination occurs because of diffusion when the syringe is open to ambient air, irrespective of the syringe position. Thus, there was a dilemma, as it was known that to prevent delivering an unknown volume of CO 2 , and preventing "explosive delivery," the patient's catheter could not be directly connected to the pressurized tank and using a syringe carried the risk of air contamination. To solve this technical predicament, a plastic bag delivery system was found to allow a controlled volume of delivery and reduce air contamination. 7, 8, 47, 48 Many safe injection systems have been described, including plastic bag delivery and automatic and mechanical injectors that do not pose the aforementioned problems. 8, 19, [48] [49] [50] However, some of these delivery systems can be complex and cumbersome for the operator, leading to modification of previously described systems.
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Contraindications and Complications
Although CO 2 is a relatively safe contrast agent, potential adverse effects have been reported. Earliest studies with intravenous CO 2 in the study of pericar- dial effusion carried no associated complications. 5, 11 In addition, gas embolism is not a known complication of CO 2 venography or arteriography. 5, 52 It seems most of the potential adverse effects of CO 2 are related to the "vapor lock" phenomenon. This results when CO 2 gas is trapped and obstructs normal blood flow, usually in cases where excessively large volumes are injected or adequate time is not allowed between serial injections to allow clearance of the CO 2 gas. 53 The "vapor lock" phenomenon is also responsible for right heart failure during venography due to obstruction of blood flow by CO 2 when excessive volumes are used or adequate time between injections is not allowed. Similarly, transient ischemic colitis and a case of transient mesenteric ischemia have also been reported after CO 2 angiography secondary to "vapor lock" phenomenon. 5, 54 An experimental study in dogs revealed an 11.9% transient decrease in renal blood flow with return to baseline in 24 hours. There was no dose-dependent effect and no histologic evidence of damage was present unless the kidney was positioned vertically, which would require a longer time to cortically clear the gas. 55 This relates to the buoyancy of CO 2 as it can become trapped in a nondependent organ or vessel, such as renal transplants and mesenteric vessels. In addition, slow dissolution may result in tissue ischemia. For example, in the evaluation of abdominal aortic aneurysms, trapped CO 2 can lead to the presence of nitrogen from tissues exchange and subsequent embolization of insoluble nitrogen can lead to ischemia. 5, 56 Therefore, allotting adequate time in between serial injections to allow clearance, changing positions to allow trapped gas to be cleared, and using low volumes of gas can avoid these potential adverse effects. Although a recommended maximum arterial injection volume of no greater than 100 mL and a maximum intravenous injection dose of 50 mL have been reported, it is likely that a higher total volume can be used so as long as small doses at a time are delivered and time is allotted between serial injections. 7, 8 Other reactions, such as nausea and vomiting, have been reported after CO 2 injection when compared with iodinated contrast injection. 30 In addition, a fatality has also been reported after CO 2 arteriography, in which a patient suffered from livedo reticularis, rhabdomyolysis, and intestinal infarction. The authors concluded an interarterial injection in a patient with impaired cardiac function as the likely mechanism. 56 With regard to CO 2 hepatic venography during TIPS, wedged techniques have been reported to be associated with hepatic lacerations as opposed to the balloon occlusion method. 57 Although no alteration in blood gas levels has been reported from the use of CO 2 , the use in patients with severe respiratory disease or chronic obstructive pulmonary disorder where CO 2 may not be readily cleared is cautioned. Although CO 2 contrasted studies have been performed without any adverse effects reported, some have recommended frequent arterial blood gas checks during the procedure as well as using a conservative volume of CO 2 and an increased time between injections in these patients. CO 2 should not be used for cerebral angiography as mixed results regarding neurotoxicity have been reported. Neurotoxicity and dose-dependent neurologic damage, including infarction and blood-brain barrier disruption, have been demonstrated in animal studies, 58 while other studies showed no such effects. 59 Despite these reported potential adverse effects, CO 2 is largely and relatively safe with only 1 complication of transient colonic ischemia in a study of 800 patients and only 7 cases of complications in a study of 1200 patients. 8, 53 For these reasons, arterial studies should be limited to below the diaphragm. Additionally, intravenous injections into the IVC should be avoided in patients with a patent foramen ovale.
Conclusions
CO 2 can serve as a suitable alternative intravascular contrast agent, especially in patients with renal failure or an iodine contrast allergy. It demonstrates an acceptable diagnostic accuracy in most applications, and in the case of TIPS, even superior to ICM. Although CO 2 is relatively safe as an intravascular agent, it does come with a technical challenge with regard to its delivery as well as a few potential adverse effects.
